These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Cholestatic hepatitis: a rare complication of the treatment with D. penicillamine]. Berbis P; Fabre JF; Privat Y Ann Dermatol Venereol; 1987; 114(3):377-9. PubMed ID: 3605968 [No Abstract] [Full Text] [Related]
4. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma]. Alekperov RT; Avdeev SN; Kotovskaia MA Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466 [No Abstract] [Full Text] [Related]
5. [D-penicillamine-induced lipoid nephrosis in a patient with scleroderma]. Kitazawa K; Ohseto Y; Kawazumi H; Saito K; Shibata T; Uchida J; Yonekura M; Shiwachi S; Ito S; Sugisaki T Ryumachi; 1982 Oct; 22(5):397-403. PubMed ID: 7157094 [No Abstract] [Full Text] [Related]
6. D-penicillamine induced crescentic glomerulonephritis: report and review of the literature. Devogelaer JP; Pirson Y; Vandenbroucke JM; Cosyns JP; Brichard S; Nagant de Deuxchaisnes C J Rheumatol; 1987 Oct; 14(5):1036-41. PubMed ID: 3430507 [TBL] [Abstract][Full Text] [Related]
7. [Penicillamine in the treatment of scleroderma. Lathyrogenic drugs]. Szczepanski A Przegl Dermatol; 1971; 58(3):355-9. PubMed ID: 4944035 [No Abstract] [Full Text] [Related]
8. Penicillamine-induced liver disease. Langan MN; Thomas P Am J Gastroenterol; 1987 Dec; 82(12):1318-9. PubMed ID: 3687909 [No Abstract] [Full Text] [Related]
9. Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases. Tio H; van Wijk L; de Haan E Acta Med Scand; 1973 May; 193(5):477-80. PubMed ID: 4717327 [No Abstract] [Full Text] [Related]
10. [Penicillamine therapy of chronic liver diseases]. Wildhirt E MMW Munch Med Wochenschr; 1974 Feb; 116(5):217-20. PubMed ID: 4205098 [No Abstract] [Full Text] [Related]
11. [Treatment of progressive scleroderma with D-penicillamine (Metalcaptase)]. Böni A; Pavelka K; Kludas M Munch Med Wochenschr; 1969 Aug; 111(31):1580-4. PubMed ID: 5394493 [No Abstract] [Full Text] [Related]
12. [Therapeutic effect of d-penicillamine in scleroderma]. Bogdanikowa B; Rudy J; Bernacka K; Palka Z Pol Tyg Lek; 1973 Aug; 28(34):1317-20. PubMed ID: 4756401 [No Abstract] [Full Text] [Related]
13. [Extra-capillary glomerulonephritis induced by D-penicillamine therapy]. Marlier S; Gisserot O; Yao N; Hecht M; Paris JF; Carli P; Chagnon A Presse Med; 1999 Apr; 28(13):689-90. PubMed ID: 10228478 [No Abstract] [Full Text] [Related]
14. [Penicillamine in the treatment of scleroderma]. Kobíková M; Stáva Z Cesk Dermatol; 1973 Dec; 48(6):408-10. PubMed ID: 4771784 [No Abstract] [Full Text] [Related]
15. [D-penicillamine in the treatment of progressive systemic sclerosis]. Marques Neto JF; Manzato LC; Samara AM AMB Rev Assoc Med Bras; 1980 Jun; 26(6):191-3. PubMed ID: 6970374 [No Abstract] [Full Text] [Related]
17. Loss of taste during therapy with penicillamine. Keiser HR; Henkin RI; Bartter FC; Sjoerdsma A JAMA; 1968 Feb; 203(6):381-3. PubMed ID: 5694119 [No Abstract] [Full Text] [Related]
18. [Experience using d-penicillamine in systemic scleroderma]. Nemchinov EN; Krel' AA; Shekhter AB; Rashchupkina ZP Klin Med (Mosk); 1982 Jan; 60(1):77-82. PubMed ID: 7078046 [No Abstract] [Full Text] [Related]